Virtu KCG Holdings’s Biogen BIIB Stock Holding History

Virtu KCG Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.91M	Sell	7,022 -6,404	-48%	-$1.69M	0.05%	268
2017 Q1	$3.67M	Buy	13,426 +10,972	+447%	+$3.1M	0.1%	105
2016 Q4	$696K	Buy	+2,454	New	+$727K	0.02%	1121
2016 Q2	–	Sell	-1,406	Closed	-$366K	–	2947
2016 Q1	$366K	Buy	1,406 +190	+16%	+$50.2K	0.01%	1495
2015 Q4	$373K	Buy	+1,216	New	+$349K	0.01%	1895
2015 Q3	–	Sell	-10,529	Closed	-$3.48M	–	3339
2015 Q2	$4.25M	Sell	10,529 -23,090	-69%	-$9.27M	0.08%	174
2015 Q1	$14.2M	Buy	33,619 +19,093	+131%	+$7.53M	0.29%	33
2014 Q4	$4.93M	Buy	14,526 +7,120	+96%	+$2.3M	0.08%	146
2014 Q3	$2.45M	Sell	7,406 -11,225	-60%	-$3.7M	0.05%	358
2014 Q2	$5.88M	Buy	18,631 +16,505	+776%	+$4.97M	0.09%	141
2014 Q1	$650K	Sell	2,126 -5,284	-71%	-$1.68M	0.01%	1658
2013 Q4	$2.07M	Sell	7,410 -274	-4%	-$70.9K	0.02%	646
2013 Q3	$1.85M	Buy	+7,684	New	+$1.72M	0.02%	674

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's BIIB Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Biogen (BIIB) stake by 48% in Q2 2017, selling an estimated $1.69M and leaving 7,022 shares worth $1.91M. The position accounts for 0.05% of the portfolio, ranked #268.

Virtu KCG Holdings first reported a position in BIIB in Q3 2013 and has held it in 13 quarters since. The position peaked at $14.2M in Q1 2015. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Virtu KCG Holdings held 7,022 shares of Biogen worth $1.91M as of Q2 2017.
Virtu KCG Holdings sold 6,404 Biogen shares in Q2 2017, an estimated $1.69M.
Biogen made up 0.05% of Virtu KCG Holdings's portfolio in Q2 2017, its #268 holding.
Virtu KCG Holdings first reported a position in Biogen in Q3 2013 and has held it in 13 quarters since.
Virtu KCG Holdings's Biogen position peaked at $14.2M in Q1 2015.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.